On July 24, Harvard’s Wyss Institute for Biologically Inspired Engineering announced a Cooperative Agreement worth up to $37 million from...

Last month’s “Science Matters” column in START-UP highlighted some newly reported cell therapy work in Parkinson’s disease, but suggested t...

A manuscript in press is suggesting that the mechanism of DPP-IV inhibitors, like Merck’s blockbuster Januvia , may eliminate a potentially...

Does anyone else sense an increase in the rate at which nanotechnology is being rationally applied to cancer diagnostics? More and more, it ...

In a short paper to appear in tomorrow’s Nature , scientists at Sirtris Pharmaceuticals describe the in vitro and in vivo data supporting ...

When orthopedists think of the biology of bone formation and remodeling, they think protein and protein signaling. They might slap platelet-...

There was little attention paid to last week's paper suggesting that PPAR delta agonists might be used to prevent the cardiovascular sid...